CID 131770041

8-hydroxynevirapine glucuronide

Structural Information

Molecular Formula
C21H22N4O8
SMILES
CC1=C2C(=NC=C1)N(C3=C(C=C(C=N3)O[C@@H]4[C@H]([C@@H]([C@H]([C@@H](O4)C(=O)O)O)O)O)C(=O)N2)C5CC5
InChI
InChI=1S/C21H22N4O8/c1-8-4-5-22-18-12(8)24-19(29)11-6-10(7-23-17(11)25(18)9-2-3-9)32-21-15(28)13(26)14(27)16(33-21)20(30)31/h4-7,9,13-16,21,26-28H,2-3H2,1H3,(H,24,29)(H,30,31)/t13-,14-,15+,16-,21+/m1/s1
InChIKey
IVZWGLRSSHUFTI-WCYOCWRHSA-N
Compound name
(2R,3R,4R,5S,6R)-6-[(2-cyclopropyl-7-methyl-10-oxo-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-13-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

0
References

3
Patents

458.14377 Da
Monoisotopic Mass

0.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 459.15105 212.9
[M+Na]+ 481.13299 220.2
[M-H]- 457.13649 215.6
[M+NH4]+ 476.17759 209.5
[M+K]+ 497.10693 219.7
[M+H-H2O]+ 441.14103 203.0
[M+HCOO]- 503.14197 215.9
[M+CH3COO]- 517.15762 217.0
[M+Na-2H]- 479.11844 210.6
[M]+ 458.14322 211.7
[M]- 458.14432 211.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe